WEREWOLF THERAPEUTICS, INC. Number of Reportable Segments
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- WEREWOLF THERAPEUTICS, INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- WEREWOLF THERAPEUTICS, INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- WEREWOLF THERAPEUTICS, INC. number of reportable segments for fiscal 2024 was 1.00 segment.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-07-31 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-27 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-11 |
Segment
| Period end | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-06-30 | 1.00 Segment S-4 · filed 2026-09-22 | |
| 2025-12-31 | 1.00 Segment S-4 · filed 2026-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |